We checked the levels of FTO and ALKBH5 expression in gemcitabine-resistant cells to confirm the function of m6A erasers in controlling gemcitabine chemosensitivity in pancreatic cancer. This evidence concerns the gene ALKBH5 and pancreatic neoplasm.